Drug intelligence / Profile preview

anthocyanin-rich extract

Development stage: Phase 2
Lead developer: University of Zurich
Modality: Small Molecules
Administration: Oral

Overview

Anthocyanin-rich extract is a natural product derived from plants such as bilberries or corn, containing high concentrations of anthocyanins—a class of polyphenolic flavonoids with potent antioxidant and anti-inflammatory properties. These extracts are studied for their potential to reduce oxidative stress, inflammation, and risk of chronic diseases such as cancer, heart disease, type 2 diabetes, and inflammatory bowel disease. The mechanism of action involves scavenging free radicals and modulating inflammatory pathways such as NF-κB signaling[1][2][5]. Clinical trials have investigated its use in conditions like ulcerative colitis[6][10].

Other names: anthocyanin-rich corn extractACRE (Anthocyanin Rich Extract)bilberry-derived anthocyanin-rich extract

Beyond the preview

Go deeper on anthocyanin-rich extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on anthocyanin-rich extract.

Explore the full profile